Insider transactions bioAffinity Technologies, Inc.

Stocks

BIAF

US09076W3079

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-10 pm EDT			5-day change	1st Jan Change
0.7666 ^USD	-1.49%		-7.64%	-35.03%

Jun. 22	BioAffinity Technologies Reports Positive Preclinical Findings for Proprietary Gene Silencing Technology Targeting Squamous and Basal Skin Cancer Cells	CI
Jun. 18	BioAffinity Technologies Closes $3.2 Million Public Offering	MT

Insider Transaction History

Latest insider transactions for bioAffinity Technologies, Inc.

Date	Insider	Type	Main position	Quantity	Price	Amount	% Market Cap.
25-08-11	Roberto Rios	Other	Director	833	-	-	0.0029%
25-01-09	Steven Girgenti	Free	Chairman	14,814	-	-	0.0951%
25-01-09	Timothy Zannes	Free	General Counsel	8,641	-	-	0.0554%
25-01-09	J. Edwards	Free	Chief Financial Officer	6,172	-	-	0.0396%
25-01-09	Xavier Reveles	Free	Chief Operating Officer	21,604	-	-	0.1386%
25-01-09	Maria Zannes	Free	Founder	37,037	-	-	0.2377%
24-11-04	J. Edwards	Free	Chief Financial Officer	100,000	-	-	0.6461%
24-09-15	J. Edwards	Other	Chief Financial Officer	28,616	-	-	0.2121%
24-06-30	Robert Anderson	Free	Director	33,784	-	-	0.2898%
24-06-30	Maria Zannes	Free	Founder	33,784	-	-	0.2898%
24-06-30	Steven Girgenti	Free	Chairman	33,784	-	-	0.2898%
24-06-30	Peter Knight	Free	Director	33,784	-	-	0.2898%
24-06-30	Stuart Diamond	Free	Director	33,784	-	-	0.2898%
24-06-30	Jamie Platt	Free	Director	33,784	-	-	0.2898%
24-06-30	Gary Rubin	Free	Director	33,784	-	-	0.2898%
24-06-30	Roby Joyce	Free	Director	33,784	-	-	0.2898%
24-06-11	Peter Knight	Free	Director	8,296	-	-	0.0712%
24-06-11	Gary Rubin	Free	Director	8,296	-	-	0.0712%
24-06-11	Maria Zannes	Free	Founder	8,296	-	-	0.0712%
24-06-11	Robert Anderson	Free	Director	8,296	-	-	0.0712%
24-06-11	Stuart Diamond	Free	Director	8,296	-	-	0.0712%
24-06-11	Jamie Platt	Free	Director	8,296	-	-	0.0712%
24-06-11	Roby Joyce	Free	Director	8,296	-	-	0.0712%
24-06-11	Steven Girgenti	Free	Chairman	8,296	-	-	0.0712%
24-04-07	Maria Zannes	Fiscal year	Founder	157,960	1.61	150K	1.3796%
24-04-03	Timothy Zannes	Fiscal year	General Counsel	158,727	1.60	150K	1.3863%
24-04-02	Steven Girgenti	Fiscal year	Chairman	163,134	1.53	150K	1.4248%
24-02-25	Robert Anderson	Fiscal year	Director	129,696	1.16	75.22K	1.3649%
24-02-15	Steven Girgenti	Free	Chairman	39,474	1.52	60K	0.4154%
24-01-30	Steven Girgenti	Free	Chairman	11,943	-	-	0.1257%
24-01-30	Vivienne Rebel	Free	Chief Technology Officer	31,847	-	-	0.3352%
24-01-30	Timothy Zannes	Free	General Counsel	6,688	-	-	0.0704%
24-01-30	Michael Dougherty	Free	Chief Financial Officer	31,847	-	-	0.3352%
24-01-30	Maria Zannes	Free	Founder	23,885	-	-	0.2514%
24-01-30	Xavier Reveles	Free	Chief Operating Officer	16,720	-	-	0.1760%
23-12-31	Jamie Platt	Free	Director	12,668	1.48	18.75K	0.1333%
23-09-30	Stuart Diamond	Free	Director	24,535	1.53	37.5K	0.2624%
23-09-30	Steven Girgenti	Free	Chairman	24,535	1.53	37.5K	0.2624%
23-09-30	Gary Rubin	Free	Director	24,535	1.53	37.5K	0.2624%
23-09-30	Robert Anderson	Free	Director	24,535	1.53	37.5K	0.2624%
23-09-30	Mohsin Meghji	Free	Director	11,867	1.58	18.75K	0.1269%
23-09-30	Peter Knight	Free	Director	24,535	1.53	37.5K	0.2624%
23-09-30	Maria Zannes	Free	Founder	24,535	1.53	37.5K	0.2624%
23-09-30	Roby Joyce	Free	Director	24,535	1.53	37.5K	0.2624%
23-09-17	Xavier Reveles	Other	Chief Operating Officer	11,474	-	-	0.1306%
23-09-17	Roby Joyce	Other	Director	603,129	-	-	6.8674%
23-06-05	Michael Dougherty	Free	Chief Financial Officer	52,356	1.91	100K	0.6146%
22-12-31	Steven Girgenti	Free	Chairman	54,707	2.13	116K	0.6536%
22-12-31	Robert Anderson	Free	Director	28,392	1.98	56.25K	0.3392%
22-12-31	Peter Knight	Free	Director	28,392	1.98	56.25K	0.3392%